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Abstract
Retrograde transport dependent on coat protein I (COPI) was impaired using two different approaches and the effects
on the retrograde transport of protein toxins were investigated. One approach was to study ldlF cells that express a
temperature-sensitive defect in the O-COP subunit of COPI. The second approach was to treat cells with 1,3-
cyclohexanebis(methylamine) (CBM), a drug that interferes with the binding of COPI to Golgi membranes. With both
approaches, cells remained sensitive to a variety of protein toxins regardless of whether the toxins contained a KDEL
motif. Moreover, cholera toxin, which contains a KDEL sequence, was observed by immunofluorescence microscopy to
enter the endoplasmic reticulum of Vero cells in the presence of CBM. These data support published evidence indicating the
presence in cells of a COPI- and KDEL receptor-independent pathway of retrograde transport from the Golgi complex to
the endoplasmic reticulum. In addition, the results suggest that certain toxins containing a KDEL motif may use either the
COPI-dependent or COPI-independent pathway of retrograde transport. 8 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cholera toxin (CT), ricin, Shiga toxin (including
Shiga-like toxin 1 or verotoxin) and Pseudomonas
aeruginosa exotoxin A (ETA) are protein toxins
that express their cytotoxic activities by catalytically
modifying substrates in the cytoplasm of mammalian
cells. Ricin and Shiga toxin arrest protein synthesis
by depurinating 28S ribosomal RNA [1,2]. ETA ar-
rests protein synthesis by transferring the ADP-ribo-
syl moiety of NADþ to elongation factor 2 [3]. CT
ADP-ribosylates a regulatory G protein that results
in activation of adenylate cyclase and elevation of
cAMP [4]. To interact with cytoplasmic substrates,
the catalytic subunits of the toxins must pass through
a membrane and enter the cytoplasm, a process that
initiates with receptor-mediated uptake of the toxins.
The receptor for CT is the ganglioside GM1 [4] and
the receptor for Shiga toxin is the glycolipid globo-
triaosylceramide [5]. Ricin binds to glycoconjugates
containing galactose [6] and can potentially use either
glycoproteins or glycolipids as a receptor. ETA in-
teracts at the cell surface with the K2-macroglobulin/
low-density lipoprotein receptor-related protein [7].
After receptor binding at the plasma membrane
and uptake into a vesicle, all four toxins are pro-
posed to use retrograde transport through the Golgi
complex to access the endoplasmic reticulum (ER)
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[8^13]. Upon entering the ER, the toxins are trans-
ported to the cytoplasm by a process that may in-
volve the Sec61p complex [14].
The best-characterized pathway of retrograde
transport through the Golgi complex is via vesicles
coated with coat protein I (COPI). COPI is a macro-
molecular protein complex that envelopes vesicles
budding from Golgi membranes [15^17]. The major
structural component of COPI is coatomer, a protein
complex comprising seven di¡erent polypeptides (K-,
L-, LP-, Q-, N-, O-, and j-COP). Although a subset of
COPI-coated vesicles may participate in anterograde
transport through the Golgi stacks towards the plas-
ma membrane [18^20], there is strong genetic and
biochemical evidence that COPI-coated vesicles are
involved in retrograde transport towards the ER
[21,22]. Retrograde cargo includes luminal ER-resi-
dent proteins that have at their C-terminus the motif
KDEL (single letter amino acid code) that speci¢es
interaction with the KDEL receptor. Upon binding
to the KDEL receptor in the Golgi complex, ER
resident proteins that have escaped the ER are cap-
tured and returned to the ER via COPI-coated
vesicles that contain the KDEL receptor. Some pro-
tein toxins, such as CT and ETA, bear a KDEL
motif (or a closely related sequence) and it has
been suggested that, once endocytosed, these toxins
exploit the KDEL receptor and COPI-coated vesicles
to reach the ER by retrograde transport [11,13].
It is intriguing that other protein toxins, such as
Shiga toxin and ricin, do not contain a KDEL se-
quence and yet appear to use retrograde transport to
enter the ER en route to the cytoplasm. In the ab-
sence of a KDEL motif, how do these toxins access a
retrograde pathway? Recently, Girod et al. [23] pre-
sented direct evidence for the presence in cells of a
COPI-independent retrograde pathway that is con-
trolled by the small G protein Rab6 [24]. Shiga toxin
appears to use this pathway to reach the cytoplasm,
explaining why this toxin does not need a KDEL
sequence [23] and the same pathway could also ac-
count for the KDEL-independent retrograde trans-
port of ricin.
Within the framework of these recent advances in
the understanding of retrograde membrane tra⁄c
and the action of protein toxins, those toxins with
a KDEL sequence, such as CT, should use a COPI-
dependent pathway to enter the ER. Therefore, dis-
ruption of COPI function should inhibit access of
this type of toxin to the ER. In this paper we im-
paired COPI function in two di¡erent ways and
studied the e¡ects on the entry of protein toxins. In
one approach, we used ldlF cells, which are a tem-
perature-sensitive mutant of Chinese hamster ovary
(CHO) cells that contain a single point mutation in
the O-COP subunit [25,26]. At the restrictive temper-
ature, ldlF cells have a severely disorganized Golgi
complex and are defective in secretion [25,27]. There
is also a loss of O-COP in ldlF cells to levels below
detection within about 2 h after shifting to the re-
strictive temperature [26,28]. The second condition to
disrupt COPI function was treating cells with 1,3-
cyclohexanebis(methylamine) (CBM), a drug that ap-
pears to interact with coatomer and inhibits coatom-
er binding to Golgi membranes [29,30]. We measured
the sensitivity of ldlF cells and cells treated with
CBM to several toxins and found that they were
sensitive to the toxins, including CT that contains
the KDEL retrieval signal. In addition, CT was ob-
served by immuno£uorescence microscopy to enter
the ER despite dysfunction of COPI-mediated retro-
grade transport. These data support evidence for the
existence of a pathway to the ER that does not de-
pend on COPI, but they also suggest that even a
toxin that contains a KDEL sequence, such as CT,
can use the COPI-independent retrograde pathway
to reach the ER.
2. Materials and methods
2.1. Materials
Ricin, bovine serum albumin and secondary anti-
bodies used with both rabbit and mouse primary
antibodies were purchased from Sigma (St. Louis,
MO, USA). CT was from Calbiochem (La Jolla,
CA, USA). P. aeruginosa ETA was from Dr. S. Lep-
pla (National Institute of Dental Research, National
Institutes of Health, Bethesda, MD, USA). Rabbit
antiserum to the CT A chain was from Drs. I. Ma-
joul and H.-D. So«ling (Universita«t Go«ttingen, Go«t-
tingen, Germany). Rabbit antiserum to mannosidase
II (mann II) was purchased from Dr. K. Moremen
(University of Georgia, Athens, GA, USA). Rabbit
antiserum to TGN-38 was generously provided by
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Dr. S. Milgram (University of North Carolina,
Chapel Hill, NC, USA). Hybridoma cells producing
monoclonal antibody M3A5 were originally from
Dr. T. Kreis. Mouse monoclonal antibody to Q-adap-
tin was purchased from Transduction Laboratories
(Lexington, KY, USA). Polyclonal antibodies to cal-
nexin and monoclonal antibodies to calreticulin and
the KDEL receptor were from StressGen Biotechnol-
ogies (Victoria, BC, Canada). Tran 35S label was
from ICN Radiochemical (Irvine, CA, USA). Dul-
becco’s modi¢ed Eagle’s medium (DMEM) was from
Irvine Scienti¢c (Santa Ana, CA, USA). Fetal bovine
serum was from HyClone (Logan, UT, USA). CBM
was from Acros Organics (Pittsburgh, PA, USA).
Floromount G was from Fisher Scienti¢c (Pitts-
burgh, PA, USA). cAMP was measured with a kit
purchased from Amersham Pharmacia Biotech (Pis-
cataway, NJ, USA).
2.2. Cells and cell culture
LdlF cells, originally derived from CHO cells, were
provided by Dr. Monty Krieger (Massachusetts In-
stitute of Technology, Cambridge, MA, USA). LdlF
cells have a point mutation in O-COP that makes
them temperature-sensitive for growth [25^27]. We
made a variant of ldlF cells that was not tempera-
ture-sensitive for growth, termed ldlF(O-COP) cells,
by transfecting ldlF cells with cDNA encoding wild-
type human O-COP. cDNA for human O-COP was
obtained from the IMAGE consortium (No. 40054)
and was subcloned into the vector pCDNA3.1(Zeo)
(Invitrogen Life Technologies, Carlsbad, CA, USA).
LdlF cells at 34‡C were transfected with puri¢ed
plasmid DNA using LipofectAmine 2000 (Invitrogen
Life Technologies) according to manufacturer’s di-
rections. The cells were then grown for 2 weeks at
34‡C with 300 Wg/ml Zeocin and the cells in 12 sur-
viving colonies were subcloned and checked for
growth at 39.5‡C. Cells from one of the colonies
that thrived at the high temperature were chosen
for further use. Vero cells and NRK cells were ob-
tained from the American Type Culture Collection
(Manassas, VA, USA). All cells were routinely
grown in DMEM supplemented with 10 mM HEPES
and 5% fetal bovine serum in incubators with 90%
air and 10% CO2 at either 34‡C, 37‡C or 39.5‡C as
required.
2.3. Protein synthesis assays
Protein synthesis was measured by the incorpora-
tion of radioactivity from Tran 35S label into acid-
insoluble protein essentially as described previously
[29]. Cells were pretreated as described in the ¢gure
legends and a toxin was added at di¡erent concen-
trations for the indicated times. Tran 35S label
(1 WCi/ml) was added for 30 min and the cells were
washed, lysed, and the lysate spotted within squares
de¢ned by gridlines drawn on ¢lter paper. The ¢lter
paper was incubated in 5% trichloroacetic acid con-
taining 0.5 mg/ml methionine for 30 min at room
temperature, washed twice for 5 min in 100% etha-
nol, and dried. Radioactivity within each square of
the grid was measured with a PhosphorImager using
volume quantitation (Molecular Dynamics, Sunny-
vale, CA, USA). The IC50 value is de¢ned as the
concentration of toxin required to inhibit protein
synthesis by 50% compared to controls that received
no toxin.
2.4. Kinetics of protein synthesis inhibition by ricin
The rate of ricin intoxication was measured by
assessing the incorporation of radioactivity from
Tran 35S label into acid-insoluble protein as de-
scribed previously [31] with modi¢cations. Cells
were plated at 2U105 cells per well in four-well cul-
ture dishes 2 days before an experiment. After over-
night incubation at 34‡C, cells were shifted to 39.5‡C
for 18 h. The cells were chilled at 0‡C and incubated
with DMEM (lacking methionine) in the presence of
ricin (100 Wg/ml) for 1 h to allow toxin binding. In-
toxication was initiated by replacing the cold me-
dium with prewarmed assay medium containing the
same concentration of toxin, and incubation was
continued at 39.5‡C. Tran 35S label (10 WCi/ml)
was added for 10 min at desired time points. The
cells were washed, lysed and radioactivity measured
as described in the preceding section. Radioactivity
in samples not treated with toxin was taken as 100%
protein synthesis.
2.5. Cholera toxin assays
The sensitivity of CHO and ldlF cells to CT was
measured by shape changes induced in the cells upon
BBAMCR 14841 3-5-02
A. Chen et al. / Biochimica et Biophysica Acta 1589 (2002) 124^139126
action of CT [32]. Cells were plated on 12 mm diam-
eter glass coverslips at 34‡C overnight followed by
incubating half of the samples at 39.5‡C for 6 h to
induce the lesion in the mutant cells. The medium
was replaced with DMEM containing the desired
concentration of CT and samples were incubated at
either 34‡C or 39.5‡C for 18 h. Cells were ¢xed in 4%
paraformaldehyde and washed with phosphate bu¡-
ered saline three times. Coverslips were mounted and
images obtained with a Nikon TE300 microscope
and a 40U apochromat lens. The width and the
length of individual cells in two ¢elds (each contain-
ing 10^20 cells) from each of two independent experi-
ments were measured and the ratio of length to
width was plotted as a function of CT concentration.
The e¡ect of CT on cAMP levels in ldlF(O-COP)
and ldlF cells was also directly measured. Cells in 24-
well culture plates were incubated at either 34‡C or
39.5‡C in DMEM containing 5% fetal bovine serum
for times indicated in the legends and the desired
concentration of CT was added. Incubation was con-
tinued for the times indicated in the ¢gures and ta-
bles at either 34‡C or 39.5‡C and the level of intra-
cellular cAMP was determined by immunological
assay according to instructions supplied with the
Amersham Pharmacia Biotech assay kit.
The e¡ect of CBM on the activity of CT with Vero
cells was also determined by measuring the levels of
cAMP essentially as described in the previous para-
graph. Vero cells cultured in 24-well plates were in-
cubated for 45 min on ice with the indicated concen-
trations of CT to allow toxin binding. DMEM
adjusted to pH 8.8 as previously described [29] was
added at 37‡C with or without 2 mM CBM. After 60
min, the cells were lysed and intracellular cAMP was
measured according to instructions supplied with the
kit.
2.6. Immuno£uorescence microscopy
LdlF cells were plated on 12 mm diameter glass
coverslips at 34‡C 1 day before an experiment. Half
of the samples were then shifted to 39.5‡C and in-
cubated as described in the ¢gure legends. For indi-
rect immuno£uorescence, cells were ¢xed in 4% para-
formaldehyde and permeabilized by 0.2% saponin for
10 min. Samples were then washed three times with
phosphate bu¡ered saline and incubated with phos-
phate bu¡ered saline containing 1% BSA for 10 min.
Primary antibodies were incubated with ¢xed and
permeabilized cells for 30 min at room temperature,
washed as in the previous sentence, followed by ad-
dition of secondary antibody and a ¢nal washing.
Vero cells were plated on glass coverslips 1 day
before an experiment. The cells were washed twice
with phosphate bu¡ered saline to remove serum fol-
lowed by incubation for 45 min on ice with 2 Wg/ml
CT in serum-free DMEM to allow toxin binding.
The medium was removed and fresh DMEM ad-
justed to pH 8.8 with or without 2 mM CBM was
added for times indicated in the ¢gure legends. The
cells were ¢xed with 4% paraformaldehyde for 10
min, washed three times with phosphate bu¡ered sa-
line and permeabilized with cold methanol for 15
min. The cells were rinsed three more times with
phosphate bu¡ered saline and incubated with phos-
phate bu¡ered saline containing 1% bovine serum
albumin. Incubations with primary and secondary
antibodies were 30 min with washings between anti-
body applications as in the previous sentence.
Coverslips were mounted and viewed with a Nikon
TE300 microscope equipped with epi-illuminated
£uorescence and a 60U lens (NA=1.4). Images
were obtained with a MicroMax digital camera
(Princeton Instruments, Trenton, NJ, USA). Pixel
intensities were adjusted to full scale and ¢gures
were assembled in Adobe Photoshop 5.5 (Adobe Sys-
tems, San Jose, CA, USA). Images were printed with
a Codonics NP 1660 printer (Cleveland, OH, USA).
3. Results
3.1. The interaction of toxins with ldlF cells
LdlF cells were examined by immuno£uorescence
microscopy after staining with various Golgi mem-
brane markers at permissive and restrictive temper-
atures to characterize aberrations in the Golgi appa-
ratus caused by the O-COP defect. Antibodies to the
L subunit of coatomer were used as a marker for
COPI. The cis/medial Golgi complex was identi¢ed
by antibodies to K-mannosidase II (mann II), a
transmembrane resident of the Golgi complex.
Anti-Q-adaptin was used to stain the trans Golgi net-
work (TGN). In ldlF cells at 34‡C, all these antibod-
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Fig. 1. The e¡ect of the lesion in ldlF cells on the subcellular distribution of L-COP, mann II and Q-adaptin. Cells at 34‡C (A,B,E,F)
were ¢xed and stained for double immuno£uorescence with primary antibodies to L-COP (A) and mann II (B) or to Q-adaptin (E)
and mann II (F). Cells incubated at 39.5‡C for 6 h (C,D,G,H) were ¢xed and stained for double immuno£uorescence with primary
antibodies to L-COP (C) and mann II (D) or Q-adaptin (G) and mann II (H). The bar in H is 10 Wm.
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ies co-localized in a typical Golgi-like pattern adja-
cent to the nucleus (Fig. 1A,B,E,F). After 6 h at
39.5‡C (Fig. 1C,D), staining for L-COP and mann
II became di¡use with small spots of £uorescence
evident, similar to what has previously been observed
in ldlF cells at the restrictive temperature [25,26,33].
Interestingly, anti-Q-adaptin continued to stain peri-
nuclear membrane at the restrictive temperature
while anti-mann II did not (Fig. 1G,H). In further
experiments, the membrane that reacted with anti-Q-
adaptin also co-localized with antibodies to TGN-38,
suggesting that the TGN, or vestiges of the TGN,
remained in ldlF cells at the high temperature (data
not shown). Altogether, the results in Fig. 1 con-
¢rmed that ldlF cells have a disorganized Golgi com-
plex at the restrictive temperature, although rem-
nants of the TGN that do not stain for mann II
appear to persist.
The fate of the KDEL receptor in the mutant cells
was also investigated. At 34‡C, the KDEL receptor
was present in a perinuclear Golgi-like pattern and in
a more di¡use distribution resembling the ER (Fig.
2A,B). After 6 h at 39.5‡C, there was no evidence for
association of the KDEL receptor with Golgi mem-
Fig. 2. The e¡ect of the lesion in ldlF cells on the subcellular distribution of the KDEL receptor and calnexin. Cells at 34‡C (A,B)
were ¢xed and stained for double immuno£uorescence with primary antibodies to the KDEL receptor (A) and calnexin (B). Cells in-
cubated at 39.5‡C for 6 h (C,D) were ¢xed and stained for double immuno£uorescence with primary antibodies to the KDEL receptor
(C) and calnexin (D). The bar in B (10 Wm) is for panels A and B. The bar in D (10 Wm) is for panels C and D.
Table 1
Sensitivity of ldlF(O-COP) and ldlF cells to ricin at 34 and
39.5‡C
Cells ‡C IC50 (ng/ml W S.E.M.)
ldlF(O-COP) 34 81W 16
ldlF 34 15W 9
ldlF(O-COP) 39.5 25W 0.4
ldlF 39.5 2.3 W 0.01
Cells were incubated at 39.5‡C for 14 h or maintained at 34‡C
and treated with di¡erent concentrations of ricin for 6.5 h.
Tran 35S was added for the last 30 min of the incubation and
the incorporation of radioactivity into acid-insoluble material
was determined as described in Section 2. Protein synthesis in
ldlF cells was not impaired by incubation at the high tempera-
ture compared to the control cells. IC50 values are the average
of three or four determinations W S.E.M.
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branes of ldlF cells (Fig. 2C,D); instead, the receptor
appeared to distribute in a di¡use pattern similar to
that for the ER marker calnexin. The absence of
COPI on perinuclear Golgi membranes, coupled
with the observation that the KDEL receptor is ap-
parently con¢ned to the ER, suggests that COPI-de-
pendent retrograde transport does not function in
the mutant cells at high temperature.
The sensitivity of control cells and ldlF cells to
ricin at permissive and restrictive temperatures is
shown in Table 1. The concentration of ricin that
reduced protein synthesis by 50% (IC50) in ldlF(O-
COP) control cells (a derivative of ldlF cells that
expresses wild-type O-COP) was 81 ng/ml at 34‡C
and 25 ng/ml at 39.5‡C, an increase in sensitivity of
3.2-fold in response to the high temperature. The
IC50 values for ricin with ldlF cells at 34‡C and
39.5‡C were 15 and 2.3 ng/ml, respectively, an in-
crease in sensitivity of 6.5-fold at the high temper-
ature. Thus, inducing Golgi dysfunction at the high
temperature did not inhibit the action of ricin com-
pared to control cells ; rather, the sensitivity of ldlF
cells to the toxin was slightly enhanced. It is not clear
why ldlF cells are approx. 5^10 times more sensitive
to ricin than control cells at either the permissive or
restrictive temperatures, but it may be related to the
fact that the level of O-COP is about half of normal
in the mutant cells even at 34‡C [26]. Thus, a mild
Golgi defect may manifest itself even at 34‡C that
slightly sensitizes the cells to ricin.
To characterize the entry of ricin into ldlF cells
with greater precision than an IC50 assay, we mea-
sured the time required for ricin to be transported
from the cell surface to the cytoplasm. Cells were
preincubated at the restrictive temperature for 18 h,
quickly chilled and incubated with saturating concen-
trations of ricin to allow occupation of cell surface
receptors. The cells were returned to the restrictive
temperature and protein synthesis was assessed at
di¡erent times. A plot of the logarithm of the inhi-
bition of protein synthesis versus time yields a
straight line in this type of analysis, and extrapola-
tion of the graph to no inhibition of protein synthesis
provides the time required for the ¢rst burst of toxin
molecules to reach the cytoplasm [34]. There was no
signi¢cant di¡erence in the time (40^45 min) at which
ricin ¢rst reached the cytoplasm of control and ldlF
cells at the high temperature (Fig. 3A). After nearly
identical lag periods, the rate of intoxication for ldlF
cells was slightly greater than that for control cells,
most likely related to the fact that ldlF cells are more
sensitive to ricin than control cells at the restrictive
temperature. This result indicates that the absence of
O-COP in the mutant cells does not limit the rate at
which ricin is transported from the cell surface to the
cytoplasm.
Fig. 3. The kinetics of ricin and CT action on control and ldlF cells at 39.5‡C. (A) Rate of protein synthesis inhibition by ricin in
control and ldlF cells at 39.5‡C. Control (E) and ldlF (a) cells were shifted to 39.5‡C for 18 h, chilled to 0‡C, and incubated with
100 Wg/ml ricin for 1 h to bind the toxin to cell surface receptors. The cells were raised to 39.5‡C by addition of warm medium con-
taining 100 Wg/ml ricin and protein synthesis was assessed at the indicated times as described in Section 2. (B) LdlF (O-COP) control
cells (E) and ldlF (a) cells were shifted to 39.5‡C for 4 h and incubated with 1 Wg/ml CT. At the times indicated, the cellular amount
of cAMP was determined as described in Section 2.
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The sensitivity of ldlF cells to ricin at the restric-
tive temperature despite dysfunction of the Golgi
complex raises the question of whether the mecha-
nism of toxin entry into the cytoplasm of the mutant
cells at high temperature is the same as in normal
cells. If the same mechanism is used for both normal
and mutant cells, then an inhibitor of toxin entry
into normal cells should also inhibit toxin entry
with ldlF cells. Brefeldin A normally inhibits the cy-
totoxicity of ricin [35] and we compared the e¡ect of
brefeldin A on the action of ricin with ldlF and
ldlF(O-COP) control cells at the restrictive tempera-
ture. Both ldlF and ldlF(O-COP) cells incubated at
39.5‡C required a higher concentration of ricin to
reduce protein synthesis in the presence of brefeldin
A (Fig. 4). This suggests that a brefeldin A-sensitive
step is required for ricin to reach the cytoplasm in
both mutant and normal cells.
Ricin does not contain a KDEL signal and the
sensitivity of ldlF cells to this toxin at high temper-
ature despite the COPI defect can be explained if
ricin uses the COPI-independent pathway of retro-
grade transport to reach the ER and hence the cyto-
plasm [23,24]. In contrast to ricin, a toxin such as CT
that bears a KDEL signal is predicted to require the
COPI-dependent pathway of retrograde transport to
reach the ER en route to the cytoplasm [23,24]. It
was of interest therefore to determine whether ldlF
cells were sensitive to CT and two di¡erent assays
were used in this determination. In the ¢rst, we ex-
ploited the observation that the elevation of cyto-
plasmic cAMP caused by CT changes the shape of
CHO cells from a rounded morphology to an elon-
gated spindle-shaped morphology and that the sensi-
tivity of CHO cells to CT can be assessed by mea-
suring the ratio of cell length to width [32]. The
elongation of mutant and CHO cells at both restric-
tive and permissive temperatures as a function of CT
concentration was about the same, indicating that
ldlF cells retained sensitivity to CT at the restrictive
temperature (Fig. 5).
The second assay for sensitivity to CT was to di-
rectly measure the e¡ect of CT on cAMP levels in
ldlF and ldlF(O-COP) control cells at 34‡C and
39.5‡C (Table 2). At 34‡C, cAMP in mutant and
control cells was elevated over 120-fold by CT. At
39.5‡C, cAMP was elevated about 120-fold in con-
trol cells and 60-fold in ldlF cells. This indicates that
ldlF cells are sensitive to CT at the high temperature
by this assay, although the increase in cAMP is not
as great as in control cells. The di¡erence between
the morphological and cAMP assays with ldlF cells
suggests that the morphological change is induced at
a level of cytoplasmic cAMP that is below the max-
Fig. 5. The sensitivity of CHO and ldlF cells to CT at permis-
sive and restrictive temperatures. Cells were plated on glass cov-
erslips at 34‡C for 1 day followed by incubation at either 34‡C
or 39.5‡C for 6 h. The medium was replaced with DMEM con-
taining the indicated concentrations of CT and incubation was
continued at either 34‡C or 39.5‡C for 18 h. Cells were ¢xed
and the length-to-width ratios were determined as described in
Section 2. F, CHO cells at 34‡C; E, CHO cells at 39.5‡C; b,
ldlF cells at 34‡C; a, ldlF cells at 39.5‡C.
Fig. 4. The e¡ect of brefeldin A on the cytotoxic activity of ri-
cin at the restrictive temperature with ldlF cells and control
cells. Cells were incubated at 39.5‡C for 14 h and treated with
di¡erent concentrations of ricin for 6.5 h. Brefeldin A (5 Wg/ml)
was added to some cells 30 min before the addition of ricin.
Tran 35S was added for the last 30 min of the incubation and
the incorporation of radioactivity into acid-insoluble material
was determined as described in Section 2. F, ldlF cells without
brefeldin A; E, ldlF cells with brefeldin A; b, ldlF(O-COP) cells
without brefeldin A; a, ldlF(O-COP) cells with brefeldin A.
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imum elevation caused by the toxin. Thus, the full
morphological response is seen with ldlF cells
although the increase in cAMP is less than with con-
trol cells. We also measured the e¡ect of brefeldin A
on the action of CT and found that the drug abol-
ished the elevation of cAMP caused by the toxin
with both mutant and control cells at the high tem-
perature (Table 2). This indicates that a brefeldin A-
sensitive event is involved in the action of CT on ldlF
cells, as with ricin, and further supports the idea that
the pathway by which toxins reach the cytoplasm is
similar in mutant and control cells at high temper-
ature.
To compare the rate at which CT increased cAMP
in mutant and control cells, cells were incubated at
the restrictive temperature to induce the defect in the
mutant cells, treated with CT, and the level of cAMP
was measured at di¡erent times up to 12 h. At 2 and
4 h after CT internalization was initiated, there ap-
peared to be a mild delay of about 30 min in the
increase of cAMP in the mutant cells, although the
maximum amount of cAMP was attained by both
mutant and control cells between 8 and 12 h (Fig.
3B). These data suggest that the transport of CT
from the plasma membrane to the cytoplasm may
be less e⁄cient when COPI is impaired in the mutant
cells at the high temperature, but the delay is not
dramatic.
We attempted in further experiments to correlate
the entry of the CT A chain into the cytoplasm of
ldlF cells at 39.5‡C with morphological observation
of the A chain entering the ER of the cells by im-
muno£uorescence microscopy, as has been done with
other cell lines [9,10]. However, the CT A chain
could not be reliably detected within the ER of either
control cells or ldlF cells at any temperature, indicat-
ing that CHO cells were not a suitable model sys-
tem for monitoring the intracellular location of CT
by immuno£uorescence microscopy. Therefore, we
turned our attention to analysis of toxin entry into
other cells under conditions of Golgi dysfunction in
the presence of CBM where the cytotoxic activity of
toxins could be correlated with morphological obser-
vations.
3.2. The interaction of toxins with CBM-treated cells
CBM inhibits coatomer binding to Golgi mem-
branes in vitro [30] and interferes with coatomer
binding to the Golgi complex of intact NRK cells
and Vero cells [29,36]. In the presence of CBM,
NRK cells did not acquire resistance to ricin; rather,
the drug slightly sensitized the cells to the toxin (Ta-
ble 3). We also tested the sensitivity of NRK cells to
ETA, which has a KDEL-like sequence, and found
that CBM also sensitized cells to this toxin (Table 3).
To extend this study to CT, the e¡ect of CBM on the
entry of CT into the cytoplasm of Vero cells was
assessed by changes in the cellular levels of cAMP
in the presence and absence of CBM. As seen in
Table 4, CBM did not inhibit the ability of CT to
elevate cAMP levels in Vero cells. Thus, CBM did
not seriously impair the entry of toxins into the cy-
Table 2
The e¡ect of CT on cAMP in ldlF(O-COP) and ldlF cells at
permissive and restrictive temperatures
Cells ‡C No CT cAMP (fmoles/104 cells
W S.E.M.)
1 Wg/ml CT 1 Wg/ml CT+
brefeldin A
ldlF(O-COP) 34 6 0.1 13.7 W 1.4
ldlF 34 6 0.1 12.4 W 0.4
ldlF(O-COP) 39.5 6 0.1 12.1 W 1.5 6 0.1
ldlF 39.5 6 0.1 6.2 W 0.5 6 0.1
Table 3
The e¡ect of CBM on the sensitivity of NRK cells to ricin and ETA
Toxin IC50 W S.E.M. (Wg/ml)
No CBM 0.5 mM CBM 1.0 mM CBM 1.5 mM CBM
Ricin 10W 0.3 5W 2 1W 0.1 2W 1
ETA 88W 5 38W5 18W 8 7W 1
Cells were incubated with the indicated concentrations of CBM for 30 min at 37‡C. Ricin or ETA was added at di¡erent concentra-
tions for 90 min and protein synthesis was measured as described in Section 2. IC50 values were determined from the dose^response
curves and each value is the mean of three independent determinations W S.E.M.
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toplasm, even toxins such as CT and ETA that con-
tain the KDEL motif.
Challenging Vero cells with CT normally causes a
greater proportion of the KDEL receptor to redis-
tribute into the ER by retrograde transport [10]. To
verify that CBM impaired KDEL receptor-mediated
retrograde transport, the in£uence of CT on the dis-
tribution of the KDEL receptor was measured with
and without CBM. Vero cells were incubated with
CT for 90 min in the presence or absence of CBM,
¢xed, and the location of the KDEL receptor was
assessed. In the absence of CBM and CT, the
KDEL receptor was in a ribbon-like perinuclear Gol-
gi pattern typical for Vero cells (Fig. 6A). The addi-
tion of CT caused the KDEL receptor to assume a
more punctate and spread pattern (Fig. 6B), re£ect-
ing redistribution of the receptor from the Golgi to
the ER as a consequence of engaging the receptor in
retrograde transport of CT [10]. In cells treated with
CBM, the Golgi complex appeared swollen, a feature
previously noted with other cells [29], and the KDEL
receptor was present in Golgi membranes (Fig. 6C).
The addition of CT did not cause any apparent re-
distribution of the KDEL receptor towards the ER
in CBM treated cells (Fig. 6D). To quantitate the
e¡ect of CT on the distribution of the KDEL recep-
tor in the presence and absence of CBM, the number
of cells in several di¡erent ¢elds either displaying a
compact or disbursed distribution of the receptor
Fig. 6. The e¡ect of CT on the distribution of the KDEL receptor in the presence and absence of CBM. Vero cells were incubated on
ice for 45 min without CT (A,C) or with 2 Wg/ml CT (B,D). Medium at pH 8.8 without CBM (A,B) or with 2 mM CBM (C,D) was
added at 37‡C for 90 min. The cells were ¢xed, incubated with antibodies to the KDEL receptor, and prepared for immuno£uores-
cence microscopy as described in Section 2. The bar is 25 Wm.
Table 4
The e¡ect of CT on cAMP levels in the presence and absence
of CBM with Vero cells
CBM cAMP (fmoles/well)
No CT 0.1 Wg/ml CT 1 Wg/ml CT
3 342 3120 3090
+ 396 2810 3050
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Fig. 7. The e¡ect of CBM on the transport of CT. Vero cells were incubated on ice for 45 min with CT (2 Wg/ml) to allow toxin
binding. Medium at pH 8.8 without CBM (A^D) or with 2 mM CBM (E^H) was added at 37‡C either for 30 min (A,B,E,F) or for
120 min (C,D,G,H). The cells were ¢xed and prepared for double immuno£uorescence by staining with antibodies to CT (A,C,E,G)
or antibodies to calreticulin (B,D,F,H). The arrowheads point to staining in the nuclear envelope. The bar is 10 Wm.
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under di¡erent conditions were counted. As seen in
Table 5, the addition of CT to cells in the absence of
CBM resulted in an obvious redistribution of the
KDEL receptor from a compact to a dispersed ap-
pearance. In the presence of CBM, this redistribution
was strongly inhibited. These data argue that the
retrograde transport of CT by a COPI and KDEL
receptor-mediated process is indeed inhibited by
CBM, consistent with the known e¡ects of CBM
on impairing COPI association with Golgi mem-
branes.
To directly assess the e¡ect of CBM on the entry
of CT into the ER, cells were exposed to CT with or
without CBM for 30 or 120 min and double-stained
for the toxin and for the ER marker calreticulin (Fig.
7). In the absence of CBM, CT appeared at 30 min in
a perinuclear pattern resembling the Golgi complex
and at 120 min CT was within the ER, as indicated
by di¡use staining similar to that for calreticulin and
especially by staining of the nuclear envelope. In the
presence of CBM, CT was again associated with a
Golgi-like stain after 30 min and was evident within
the nuclear envelope by 120 min. These data support
the conclusion that CBM inhibits neither the eleva-
tion of cAMP caused by CT nor the transport of CT
to the ER.
4. Discussion
We analyzed in this paper the interaction of toxins
with cells in two di¡erent model systems that should
disrupt retrograde transport dependent on COPI and
the KDEL receptor. In ldlF cells, which lack the O-
COP subunit at the restrictive temperature, L-COP
and mann II were distributed throughout the cyto-
plasm, often in punctate structures, and not present
in a perinuclear location typical for the Golgi com-
plex. This is similar to what has been reported by
others who have studied ldlF cells by immuno£uo-
rescence and electron microscopy [25,27,33] and veri-
¢es that the Golgi apparatus is severely disrupted
upon incubating the mutant cells at the restrictive
temperature. We also noted that the KDEL receptor
was not present in a Golgi-like morphology in ldlF
cells at high temperature; rather, it appeared to be in
the ER, suggesting it was not available to participate
in retrograde transport. In the second system, cells
were treated with CBM, a drug that interferes with
the binding of COPI to Golgi membranes [29,30,36]
and which should disrupt COPI-dependent retro-
grade transport. To con¢rm the disruption of retro-
grade transport, the e¡ect of CBM on the CT-in-
duced redistribution of the KDEL receptor from
Golgi membranes to the ER was measured. In the
absence of CBM, CT induced an obvious redistrib-
ution of the KDEL receptor away from the Golgi
complex that is diagnostic for COPI-mediated retro-
grade transport. This redistribution was not evident
in cells treated with CBM. These observations pro-
vide con¢dence that retrograde transport mediated
by COPI and the KDEL receptor are seriously im-
paired in ldlF cells at high temperature and in cells
treated with CBM.
When control cells were shifted from the permis-
sive to the restrictive temperature, their sensitivity to
ricin increased about 3-fold. The sensitivity of ldlF
cells to ricin was increased 6-fold after the temper-
ature shift. Thus, impairing COPI function at the
high temperature did not cause resistance to ricin;
rather, it slightly sensitized the cells to this toxin.
There was also no signi¢cant di¡erence between mu-
tant and control cells in the rate at which ricin ¢rst
began to inhibit protein synthesis at the high temper-
ature, evidence that the defect in COPI had no e¡ect
on the rate of ricin transport from the cell surface to
the cytoplasm. One potential explanation for the sen-
sitivity of ldlF cells to ricin at the restrictive temper-
ature is that a new and distinct pathway for reaching
the cytoplasm independent of COPI is induced by
high temperature only in the mutant cells. Two ob-
servations argue against this explanation. First, bre-
feldin A inhibited the e¡ect of ricin on both control
cells and ldlF cells at the high temperature. Brefeldin
A disables ARF guanine nucleotide exchange factors
Table 5
Quantitative analysis of the e¡ect of CT on the distribution of
the KDEL receptor in the presence and absence of CBM
Number of cells CT CBM Compact
(%)
Dispersed
(%)
38 3 3 84 16
57 + 3 14 86
49 3 + 75 25
74 + + 68 32
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[37], suggesting that the action of ricin on both con-
trol and ldlF cells depends on a brefeldin A-sensitive
exchange factor, consistent with the idea that ricin
uses a similar pathway to enter both cell types. Sec-
ond, the time required for ricin transport from the
cell surface to the cytoplasm was the same for mu-
tant and control cells at the restrictive temperature.
This interval re£ects the accumulated time of the
various events involved in the transport process
and the fact that the interval is the same for mutant
and control cells is consistent with the idea that the
transport process is the same. A more likely explan-
ation for why ldlF cells remain sensitive to ricin at
the high temperature is that they exploit a COPI-
independent pathway normally present in cells to
reach the cytoplasm.
The sensitivity of ldlF cells to CT at the high tem-
perature was the same as that of control cells in the
morphological assay. In the direct assay for the e¡ect
of CT on cytoplasmic cAMP, the level of cAMP in
ldlF cells was increased about 60-fold by CT at the
high temperature, half the increase seen with control
cells. The rate at which CT increased cAMP in the
mutant cells was mildly delayed compared to control
cells at early time points, but the maximum increase
was observed about 8 h after toxin addition for both
mutant and control cells. This argues that the ability
of CT to a¡ect cAMP in the mutant cells at the high
temperature in longer assays is not due to a few CT
molecules that enter the cytoplasm of the mutant
cells very slowly compared to the control cells. It is
not clear why cAMP in the mutant cells was not
increased to the same level as seen in control cells.
One explanation is that two populations of mutant
cells are present, one that responds fully to CT and
the other that does not respond, resulting in an in-
termediate increase in the level of cAMP. However,
the morphological assay, which measures the shape
of individual cells, indicates that almost all cells in
the mutant population respond to CT by changing
shape. Thus, it is not likely that there are non-re-
sponding cells in the population. Although it is un-
certain why CT does not increase cAMP levels in
ldlF cells as much as in control cells, it is clear that
ldlF cells retain signi¢cant sensitivity to CT despite
the disruption in COPI.
Treating NRK cells with CBM to impair COPI
function mildly enhanced sensitivity to ricin and
ETA. The reason for this is unknown, but may
stem from defects in secretion that occur when
COPI is impaired, which should in turn impair lyso-
some biogenesis. Impaired lysosome biogenesis might
lead to less e¡ective degradation of toxins and con-
sequently enhance cytotoxicity by increasing the life-
time of active toxins in the cell. It is known, for
example, that impairing lysosome activity with drugs
sensitizes cells to a variety of protein toxins [38,39].
CBM did not inhibit the ability of CT to elevate
cAMP levels, nor did CBM block the transport of
CT to the ER, as indicated in immuno£uorescence
studies. Although the conclusions based on work
with CBM are subject to the caveat that there could
be nonspeci¢c e¡ects with this drug that are not ap-
parent, the results suggest that functional COPI is
not essential for certain toxins to reach the ER, in-
cluding toxins that bear a KDEL signal.
The model that has emerged for the tra⁄cking of
protein toxins that enter the ER en route to the
cytoplasm is that toxins lacking a KDEL signal use
the recently discovered COPI-independent pathway
of retrograde transport, while toxins that bear a
KDEL signal engage the KDEL receptor and use
the COPI-dependent pathway [23,24,40]. The data
presented here for ricin, which has no KDEL signal,
support the existence of a COPI-independent path-
way because ricin reached the cytoplasm even after
COPI function was disrupted in two di¡erent ways.
However, neither method of inhibiting COPI blocked
the transport of CT to the cytoplasm, a surprising
result because CT bears a KDEL signal. Moreover,
CBM did not inhibit the transport of ETA to the
cytoplasm and ETA also bears a KDEL-like signal.
These results suggest that CT and ETA, and possibly
other toxins that have a KDEL signal, can neverthe-
less engage the COPI-independent pathway and ac-
cess the ER by a pathway that does not involve
interaction of the KDEL motif with the KDEL re-
ceptor. Thus, there may be two pathways by which a
toxin bearing a KDEL sequence can enter the ER
and when one pathway is disrupted, the alternative is
available.
If a toxin containing a KDEL motif can reach the
ER by two pathways, one that requires the KDEL
signal and another that does not, then the presence
of the KDEL signal would not seem essential to
target a toxin to the ER, raising the question of
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what is the function of the KDEL signal present on
some toxins. In addition to targeting toxins to the
COPI-dependent pathway, an additional function of
the KDEL signal could be that it contributes to cy-
totoxicity by facilitating retrieval back to the ER of
toxin molecules that have entered the ER and then
escaped, regardless of how the toxins initially entered
the ER. Retrieval would presumably help maintain a
higher concentration of toxin molecules in the ER,
thus enhancing cytotoxicity. A role for the KDEL
motif in retrieving toxins back to the ER is consis-
tent with most of the data on toxin entry. Micro-
injected antibodies to the KDEL receptor and L-
COP cause toxins that bear the KDEL signal to ac-
cumulate in the Golgi complex [23,41,42]. This accu-
mulation would be predicted regardless of how the
toxin entered the Golgi, either from endosomes in a
retrograde direction or from the ER in an anterog-
rade direction for toxins that had already entered the
ER by a COPI-independent pathway. In both instan-
ces, KDEL-bearing ligands would bind the KDEL
receptor trapped within Golgi cisternae and become
trapped there themselves. The redistribution of the
KDEL receptor from the Golgi complex towards
the ER in the presence of CT [10] and ETA [42] is
also compatible with the retrieval model as redistrib-
ution of the KDEL receptor from the Golgi to the
ER was originally discovered for ligands coming
from the ER [43].
If binding of the KDEL motif at the C-terminal
end of a toxin to the KDEL receptor were essential
to engage a pathway of membrane tra⁄c that deliv-
ered the toxin to the ER, then removal of the KDEL
signal from the toxin should strongly impair cyto-
toxic activity. However, removal of the KDEL se-
quence from CT reduces, but does not strongly
block, CT activity [13]. Moreover, removing the
KDEL-like sequence from Escherichia coli heat-labile
toxin, which is very similar to CT, has little e¡ect on
activity [44]. The mild inhibition of cytotoxicity
caused by removal of the KDEL motif from these
toxins is consistent with the idea that there are two
pathways a toxin may take to the ER: toxin trans-
port still occurs when one pathway is unavailable,
but less e⁄ciently than when both are active. Attenu-
ation of cytotoxicity when one pathway of retrograde
transport is inhibited may also underlie our observa-
tions that the action of CT is mildly delayed in ldlF
cells at high temperature and that CT does not ele-
vate cAMP as much in ldlF cells at high temperature
as in control cells.
Although removal of the KDEL sequence from
CT mildly reduces cytotoxicity, removal of the
KDEL-like motif (REDLK) from ETA strongly im-
pairs cytotoxicity [11]. This seems to argue that en-
gaging the COPI-dependent pathway is critical to
deliver ETA to the ER. However, it is di⁄cult to
judge the signi¢cance of this argument because
ETA has more complicated requirements for intox-
ication than some other toxins. For example, ETA
containing the normal REDLK sequence fails to
bind the KDEL receptor in vitro [45]. The terminal
lysine residue can be removed by a protease present
in plasma to generate a form of ETA that does bind
the KDEL receptor, but the a⁄nity of the interac-
tion is lower than would be expected for e⁄cient
intoxication [46]. Thus, ETA may not be a good
paradigm for assessing the e¡ects of KDEL-like se-
quences on a toxin.
In summary, the results presented here are consis-
tent with the following model for the retrograde
transport of toxins to the ER. The toxins are inter-
nalized by receptor-mediated endocytosis and trans-
ported to the TGN. Two pathways lead from the
TGN to the ER, one via retrograde transport
through the Golgi cisternae that uses COPI and the
KDEL receptor, and a distinct COPI-independent
pathway. Toxins that have no KDEL sequence are
channeled to the COPI-independent pathway and
then to the ER. Certain toxins that contain a
KDEL signal, such as CT, can exploit either the
COPI-dependent or the COPI-independent pathway
to reach the ER. Once within the ER, toxins that
bear a KDEL signal and which escape the ER by
entering the anterograde secretory pathway to the
Golgi complex are retrieved back to the ER by the
same COPI-dependent and KDEL receptor-depen-
dent pathway that retrieves soluble resident ER pro-
teins.
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